Chapter 101
description
Transcript of Chapter 101
![Page 1: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/1.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.
Chapter 101Chapter 101
Anticancer Drugs I: Cytotoxic Anticancer Drugs I: Cytotoxic AgentsAgents
![Page 2: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/2.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 2
Cytotoxic Anticancer DrugsCytotoxic Anticancer Drugs Largest class of anticancer drugsLargest class of anticancer drugs Act directly on cancer cells and healthy cells Act directly on cancer cells and healthy cells
to cause their death to cause their death About 50% of cytotoxic anticancer drugs are About 50% of cytotoxic anticancer drugs are
phase-specificphase-specific Subdivided into nine major groupsSubdivided into nine major groups
![Page 3: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/3.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 3
Anticancer DrugsAnticancer Drugs Cytotoxic drugsCytotoxic drugs
Alkylating agentsAlkylating agents Platinum compoundsPlatinum compounds AntimetabolitesAntimetabolites Hypomethylating agentsHypomethylating agents Antitumor antibioticsAntitumor antibiotics Mitotic inhibitorsMitotic inhibitors Topoisomerase inhibitorsTopoisomerase inhibitors Miscellaneous cytotoxic drugsMiscellaneous cytotoxic drugs
![Page 4: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/4.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 4
![Page 5: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/5.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 5
Cell-Phase SpecificityCell-Phase Specificity Sequence of events that a cell goes through Sequence of events that a cell goes through
from one mitotic division to the nextfrom one mitotic division to the next Cell-cycle phase–specific drugsCell-cycle phase–specific drugs
Toxic only to cells that are in a particular phaseToxic only to cells that are in a particular phase Must be in the in the blood continuously over a Must be in the in the blood continuously over a
long timelong time Cell-cycle phase–nonspecific drugsCell-cycle phase–nonspecific drugs
Can act during any phase of the cell cycleCan act during any phase of the cell cycle
![Page 6: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/6.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 6
ToxicityToxicity Many anticancer drugs are toxic to normal Many anticancer drugs are toxic to normal
tissues – especially tissue with high growth tissues – especially tissue with high growth fractionfraction Bone marrowBone marrow Hair folliclesHair follicles GI epitheliumGI epithelium Germinal epitheliumGerminal epithelium
![Page 7: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/7.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 7
Dosage, Handling, and Dosage, Handling, and AdministrationAdministration
Antineoplastic drugs are often mutagenic, Antineoplastic drugs are often mutagenic, teratogenic, and carcinogenicteratogenic, and carcinogenic
Direct contact can result in local injuryDirect contact can result in local injury Extravasation of vesicantsExtravasation of vesicants
Carmustine, dacarbazine, dactinomycin, Carmustine, dacarbazine, dactinomycin, daunorubicin, doxorubicin, mechlorethamine, daunorubicin, doxorubicin, mechlorethamine, mitomycin, plicamycin, streptozocin, vinblastine, mitomycin, plicamycin, streptozocin, vinblastine, vincristinevincristine
![Page 8: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/8.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 8
Alkylating AgentsAlkylating Agents Highly reactive compoundsHighly reactive compounds Cells are killed by the alkalization of DNACells are killed by the alkalization of DNA Cell-cycle phase–nonspecific agentsCell-cycle phase–nonspecific agents Drug resistance is commonDrug resistance is common ToxicitiesToxicities
Occur in tissues with high growth fractionOccur in tissues with high growth fraction• Bone marrow, hair follicles, GI mucosa, and germinal Bone marrow, hair follicles, GI mucosa, and germinal
epitheliumepithelium
![Page 9: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/9.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 9
Fig. 101-1. Cross-linking of DNA by an alkylating agent.A, Reactions leading to cross-linkage between guanine moieties in DNA. B, Schematic representation of interstrand cross-linking within the DNA double helix. (A = adenine, C = cytosine, G = guanine, T = thymine.)
![Page 10: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/10.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 10
Classes of Alkylating AgentsClasses of Alkylating Agents Nitrogen mustardsNitrogen mustards
Cyclophosphamide (Cytoxan)Cyclophosphamide (Cytoxan) NitrosoureasNitrosoureas
Carmustine (BCNU)Carmustine (BCNU) OtherOther
Temozolomide (Temodar)Temozolomide (Temodar) Busulfan (Myleran)Busulfan (Myleran)
![Page 11: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/11.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 11
Platinum CompoundsPlatinum Compounds Cell-cycle phase–nonspecific agentsCell-cycle phase–nonspecific agents Cisplatin (Platinol-AQ)Cisplatin (Platinol-AQ) Carboplatin (Paraplatin)Carboplatin (Paraplatin) Oxaliplatin (Eloxatin)Oxaliplatin (Eloxatin)
![Page 12: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/12.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 12
AntimetabolitesAntimetabolites Folic acid analog Folic acid analog
Methotrexate (Rheumatrex) Methotrexate (Rheumatrex) Pemetrexed (ALIMTA)Pemetrexed (ALIMTA)
Pyrimidine analogsPyrimidine analogs Cytarabine (Cytosar-U)Cytarabine (Cytosar-U) Fluorouracil (Adrucil)Fluorouracil (Adrucil) Capecitabine (Xeloda)Capecitabine (Xeloda) Floxuridine (FUDR)Floxuridine (FUDR) Gemcitabine (Gemzar)Gemcitabine (Gemzar)
![Page 13: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/13.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 13
AntimetabolitesAntimetabolites Purine analogsPurine analogs
Mercaptopurine (Purinethol) Mercaptopurine (Purinethol) Thioguanine (Tabloid)Thioguanine (Tabloid) Pentostatin (Nipent)Pentostatin (Nipent) Fludarabine (Fludara)Fludarabine (Fludara) Cladribine (Leustatin)Cladribine (Leustatin) Nelarabine (Arranon)Nelarabine (Arranon)
![Page 14: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/14.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 14
Fig. 101-2. Actions of methotrexate, leucovorin, and fluorouracil.(FdUMP = 5-fluoro-2'-deoxyuridine-5'-monophosphate, X = blockade of reaction.)
![Page 15: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/15.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 15
Hypomethylating AgentsHypomethylating Agents New class of anticancer drugsNew class of anticancer drugs Become incorporated into the DNABecome incorporated into the DNA Azacitidine (Vidaza)Azacitidine (Vidaza) Decitabine (Dacogen)Decitabine (Dacogen)
![Page 16: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/16.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 16
Antitumor AntibioticsAntitumor Antibiotics Cytotoxic drugs originally isolated from Cytotoxic drugs originally isolated from
cultures of cultures of StreptomycesStreptomyces Used only to treat cancer – not infectionsUsed only to treat cancer – not infections Injure cells through direct interaction with Injure cells through direct interaction with
DNADNA Poor GI absorption – IV administrationPoor GI absorption – IV administration Two main groupsTwo main groups
Anthracyclines and nonanthracyclinesAnthracyclines and nonanthracyclines
![Page 17: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/17.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 17
AnthracyclinesAnthracyclines Doxorubicin (Adriamycin)Doxorubicin (Adriamycin) Doxorubicin liposomal (Doxil)Doxorubicin liposomal (Doxil) Daunorubicin (DaunoXome)Daunorubicin (DaunoXome) Epirubicin (Ellence)Epirubicin (Ellence) Idarubicin (Idamycin)Idarubicin (Idamycin) Mitoxantrone (Novantrone)Mitoxantrone (Novantrone)
![Page 18: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/18.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 18
NonanthracyclinesNonanthracyclines Dactinomycin (Actinomycin D)Dactinomycin (Actinomycin D) Bleomycin (Blenoxane)Bleomycin (Blenoxane) Mitomycin (Mutamycin)Mitomycin (Mutamycin)
![Page 19: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/19.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 19
Mitotic InhibitorsMitotic Inhibitors Vinca alkaloids Vinca alkaloids
Vincristine (Oncovin)Vincristine (Oncovin) Vinblastine (Velban)Vinblastine (Velban) Vinorelbine (Navelbine)Vinorelbine (Navelbine)
TaxanesTaxanes Paclitaxel (Taxol)Paclitaxel (Taxol) Docetaxel (Taxotere)Docetaxel (Taxotere)
![Page 20: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/20.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 20
Other Mitotic InhibitorsOther Mitotic Inhibitors Ixabepilone (Ixempra)Ixabepilone (Ixempra) Estramustine (Emcyt)Estramustine (Emcyt)
![Page 21: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/21.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 21
Topoisomerase InhibitorsTopoisomerase Inhibitors Nuclear enzymes that alter the shape of Nuclear enzymes that alter the shape of
supercoiled DNAsupercoiled DNA Topotecan (Hycamtin)Topotecan (Hycamtin) Irinotecan (Camptosar)Irinotecan (Camptosar) Etoposide (VePesid)Etoposide (VePesid) Teniposide (Vumon)Teniposide (Vumon)
![Page 22: Chapter 101](https://reader035.fdocuments.net/reader035/viewer/2022062520/56815ccc550346895dcad9f4/html5/thumbnails/22.jpg)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. 22
Miscellaneous Cytotoxic DrugsMiscellaneous Cytotoxic Drugs Asparaginase (Elspar)Asparaginase (Elspar) Pegaspargase (Oncaspar)Pegaspargase (Oncaspar) Hydroxyurea (Hydrea, Mylocel)Hydroxyurea (Hydrea, Mylocel) Mitotane (Lysodren)Mitotane (Lysodren) Procarbazine (Matulane)Procarbazine (Matulane) Dacarbazine (DTIC-Dome)Dacarbazine (DTIC-Dome)